Kandasamy Hariharan

This inventor holds 12 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent. Top assignees: Celgene Corporation, Biogen Idec, Inc., Biogen Idec Ma Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kandasamy Hariharan. Retrieved from https://idiyas.com/inventor/kandasamy-hariharan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 12)

% Patents Active = 91.7

CIPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 5.9

ph-index = 6

Forward Citations = 173(Granted Patents)

Company Filing History:

Years Active: 2005-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545740 - ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47 (2026-02-10),

2. 12428488 - Engineering of an antibody for tumor-selective binding of CD47 (2025-09-30),

3. 12084499 - SIRP-α binding proteins and methods of use thereof (2024-09-10),

4. 11591390 - SIRP-α binding proteins and methods of use thereof (2023-02-28),

5. 11427632 - Antibodies with low immunogenicity and uses thereof (2022-08-30),

6. 11401336 - BCMA-binding antibodies and uses thereof (2022-08-02),

7. 10428145 - PD-1 binding proteins and methods of use thereof (2019-10-01),

8. 8147829 - Anti-IGR-1R antibodies and uses thereof (2012-04-03),

9. 7612178 - Anti-IGF-1R antibodies and uses thereof (2009-11-03),

10. 7319139 - [object Object] (2008-01-15),

11. 6998125 - Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis (2006-02-14),

12. 6897044 - Production of tetravalent antibodies (2005-05-24),

Title: A Profile of Inventor Kandasamy Hariharan

Introduction

Kandasamy Hariharan is an accomplished inventor based in San Diego, California. With an impressive portfolio of ten patents, he has made significant contributions to the field of biotechnology. His work primarily revolves around proteins and their applications in modulating biological activities.

Latest Patents

Among his latest innovations are patents related to SIRP-α binding proteins. These patents provide compositions, methods, and uses involving antibodies that specifically bind to the signal regulatory protein-α (SIRPα) and modulate its activity. Such advancements hold great potential for therapeutic applications, enhancing the capability to influence immune responses.

Career Highlights

Throughout his career, Kandasamy has worked with leading biotechnology firms, including Celgene Corporation and Biogen Idec, Inc. His expertise has been instrumental in advancing research and development in these organizations, allowing for breakthroughs that align with current medical needs.

Collaborations

Kandasamy has collaborated with notable professionals in his field, including Jeonghoon Sun and Gary R Braslawsky. These partnerships have enriched his work and expanded the scope of his empirical studies, contributing to the successful completion of his patents.

Conclusion

Kandasamy Hariharan exemplifies the innovative spirit of modern inventors. His contributions, particularly in the realm of SIRP-α binding proteins, highlight his commitment to advancing healthcare through scientific research. The impact of his work continues to resonate within the biotechnology sector, paving the way for future innovations.

Profile summary based on public USPTO records.